[1] 石卫晨,吴蓉,蔡利红. 浅谈“双心”疾病的研究现状及方向[J]. 现代临床医学,2015,41(3):230-232,236.
[2] Gerk U, Mrowietz C, Sternitzky R, et al. Effect of ioxaglate on the cutaneous microcirculation in patients with coronary artery disease: Randomized, double blind, placebo-controlledstudy[J]. Clin Hemorheol Microcirc, 2016, 64(3): 297-304.
[3] Balaji S, Sreeram N. The development of pacing induced ventricular dysfunction is influenced by the underlying structural heart defect in children with congenital heartdisease[J]. Indian Heart J, 2017, 69(2): 240-243.
[4] 王超,王昀,赵海滨. 从中医“双心学说”探析冠心病合并焦虑的论治思路[J]. 环球中医药,2016,9(12):1476-1478.
[5] 吴建萍,党晓晶,孙海娇,等. 双心疾病的中医药论治思路[J]. 中医杂志,2016,57(2):115-117.
[6] 国际心脏病学会和协会及世界组织命名标准联合专题组. 缺血性心脏病的命名及诊断标准[J]. 中华心血管病杂志,1991,9(1):75
[7] 段泉泉,胜利. 焦虑及抑郁自评量表的临床效度[J]. 中国心理卫生杂志,2012,26(9):676-679.
[8] 国家中医药管理批准发布.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:215.
[9] Liskova YV, Stadnikov AA, Salikova SP. Role of telocytes in the heart in health anddiseases[J]. Arkh Patol, 2017, 79(2): 58-63.
[10] 张欢. 中西医结合认识“双心医学”[J]. 中西医结合心血管病电子杂志,2015,3(15):193-194.
[11] Giugliano RP, Mach F, Zavitz K, et al. Design and rationale of the ebbinghaus trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy-A cognitive study of patients enrolled in the fourier trial[J]. Clin Cardiol, 2017, 40(2): 59-65.
[12] 王鑫焱,赵中华. 邓悦教授治疗冠心病的用药经验浅析[J]. 环球中医药,2015,8(11):1373-1376.
[13] 焦晓民,阮琳. 浅谈中医辨证论治双心疾病[J]. 辽宁中医杂志,2015,42(4):721-723.
[14] 王涛,王世钦. 舒肝镇心汤治疗肝气郁结证双心疾病疗效观察[J]. 中国中医急症,2014,23(12):2327-2329.
[15] 郭道群. 抑肝散合黛力新治疗双心疾病疗效观察[J]. 中国实用医药,2014,9(19):196-197.
[16] 黄世敬,谭赛,陈宇霞. 合欢抗抑郁研究进展[J]. 吉林中医药,2014,34(3):318-321.
[17] Fang W, Yang YJ, Guo BL, et al. Anti-influenza triterpenoid saponins(saikosaponins)from the roots of bupleurum marginatum var. stenophyllum[J]. Bioorg Med Chem Lett, 2017, 27(8): 1654-1659.
[18] Sim Y, Choi JG, Gu PS, et al. Identification of neuroactive constituents of the ethyl acetate fraction from cyperi rhizoma using bioactivity-guided fractionation[J]. Biomol Ther(Seoul), 2016, 24(4): 438-445.
[19] 汪火生,卢爱丽. 中医疏肝解郁法治疗“双心疾病”的临床疗效观察[J]. 中国医药导刊,2017,19(03):233-234,236.
[20] Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease[J]. N Engl J Med, 2017, 376(18): 1713-1722.
[1]逄冰,赵锡艳,彭智平,等.仝小林教授糖尿病合并冠状动脉粥样硬化性心脏病诊治验案1则[J].环球中医药,2012,5(11):842.
[2]江丽杰 胡镜清 李瑞杰 李然.冠心病痰瘀互结证基本脉象及其影响因素[J].环球中医药,2015,8(06):641.[doi: A doi:10.3969/j.issn.1674-1749.2015.06.001]
JIANG Li-jie,HU Jing-qing,LI Rui-jie,et al.Pulse manifestations and influence factors of coronary heart disease with intermingled phlegm-blood stasis syndrome[J].,2015,8(12):641.[doi: A doi:10.3969/j.issn.1674-1749.2015.06.001]
[3]冒慧敏,刘秀华,史大卓.桃红四物汤治疗冠心病的机制研究进展[J].环球中医药,2016,9(09):1145.[doi:10.3969/j.issn.1674-1749.2016.09.039]
MAO Hui-min,LIU Xiu-hua,SHI Da-zhuo..Research progress on the mechanism of Taohong Siwu decoction in the treatment of coronary atherosclerotic heart disease[J].,2016,9(12):1145.[doi:10.3969/j.issn.1674-1749.2016.09.039]
[4]王超,王昀,赵海滨.从中医“双心学说”探析冠心病合并焦虑的论治思路[J].环球中医药,2016,9(12):1476.[doi:10.3969/j.issn.1674-1749.2016.12.010]
[5]匡武.王焕禄辨治冠状动脉粥样硬化性心脏病学术经验总结[J].环球中医药,2016,9(12):1515.[doi:10.3969/j.issn.1674-1749.2016.12.025]
[6]王昀 李蕊 吴弈姗 张晗 赵海滨.从李东垣“阴火”学说探讨冠心病室性早搏的论治思路[J].环球中医药,2017,10(02):208.[doi:10.3969/j.issn.1674-1749.2017.02.022]
[7]柴华 曲华 梁芳.史大卓教授基于“虚”“瘀”“痰”理论辨治冠心病的临床经验[J].环球中医药,2017,10(06):604.[doi:10.3969/j.issn.1674-1749.2017.06.016]
[8]宋丽波 董国菊 杨丽丽 梁孟女 张微.健身气功六字诀对冠心病合并抑郁状态患者的影响[J].环球中医药,2017,10(08):869.[doi:10.3969/j.issn.1674-1749.2017.08.017]
[9]宋丽波,李静,陈晓燕,等.刮痧疗法在冠心病血瘀证中的研究现状及展望[J].环球中医药,2017,10(10):1174.[doi:10.3969/j.issn.1674-1749.2017.10.037]
SONG Libo,LI Jing,CHEN Xiaoyan,et al.Research status and prospect of scraping therapy in coronary heart disease with blood stasis syndrome[J].,2017,10(12):1174.[doi:10.3969/j.issn.1674-1749.2017.10.037]
[10]刘签兴,刘如秀.国医大师刘志明从“肾虚血瘀”论治冠心病经验[J].环球中医药,2017,10(12):1506.[doi:10.3969/j.issn.1674-1749.2017.12.026]